Flexible Bioelectronics: Revolutionizing Cancer Treatment
We have developed a disruptive technology that will change the way cancer is treated. We implant soft, flexible electrodes into tumours, and use electricity to kill and control cancer. We will extend and improve the quality of patients’ lives.
Innovative Technology
Targeting
Aggressive Cancers
Oncoelectronics develops implantable and surgical bioelectronic devices that deliver targeted therapies to aggressive tumors. Built on more than a decade of preclinical research, our innovations harness the power of pulsed electric fields to enhance treatment efficacy and safety. We are translating cutting-edge science into clinical solutions for patients who need them most.
Precision Therapy
Targets tumors with unparalleled accuracy using advanced electrical stimulation informed by sensors.
Innovative Design
Soft, flexible implants are seamlessly integrated into existing surgical workflow.
Enhanced Outcomes
We will improve patient survival and quality of life with this revolutionary approach.
Bioelectronic
Cancer Treatment
Precision Cancer Treatment
We are pioneering implantable cancer therapies using pulsed electric fields, sensors, and AI.
Direct Tumor
Control
Shrinking Cancer Burden
Our device demonstrated a significant reduction in tumor size during preclinical trials.
Immunogenic Response
Activates the Immune System
Our technology has demonstrated a significant improvement in tumor immunogenicity.
Oncoelectronics is led by founders with expertise in oncology, bioengineering, and advanced medical technologies, focused on delivering breakthrough cancer therapies.
Alanna Harlton CEO
Chief Executive Officer
Rod O’Connor PhD
Chief Scientific Officer
Martin Bača PhD
Chief Technology Officer
Top 30 Innovative Companies
VivaTech 2025
Oncoelectronics selected in the
Top 30 Innovative Companies
from 14,000 companies presenting at
VivaTech 2025 Paris France
Top 30 Female Founders
VivaTech 2025
CEO Alanna Harlton selected for
Top 30 Female Founders
VivaTech 2025 Paris France
Bpifrance & Region Sud
PIA 4 Award 2025
France 2030 initiative
Oncoelectronics wins PIA 4 award
from Bpifrance, Banque Publique d’Investissement
and Region Sud under France 2030 initiative
Invest in Provence 2025
Provence Promotions
Oncoelectronics presented with
Invest in Provence Award 2025
Provence Promotions Marseille France
IGEU IMT Award 2024
Industrie & Energie 4.0
Oncoelectronics wins award from
Initiative Grandes Ecoles et Universités
for Institut Mines-Télécom 2024
Bpifrance BFTE Award 2024
Bourse French Tech Emergence
Oncoelectronics wins Bourse French Tech Emergence
Award promoting the emergence of Deeptech startups
from Bpifrance, Banque Publique d’Investissement
Top Female Founders 2024
European Institute of
Innovation & Technology
CEO Alanna Harlton selected in
Top Female Founders 2024
European Institute of Innovation & Technology
Oncoelectronics Featured
Cancer Showcase 2024
Canadian Cancer Society
Oncoelectronics presents by special invitation
at the Cancer Showcase 2024
hosted by the Canadian Cancer Society
and Creative Destruction Labs
Creative Destruction Labs
Global Cancer Stream 2024
Finalists Vancouver BC
Oncoelectronics graduated the
Global Cancer Stream 2024
hosted by Creative Destruction Labs
Innovation in Health Award
First Prize 2024
Oncoelectronics wins First Prize
L’innovation pour notre santé 2024
from Crédit Agricole Alpes Provence
Transforming Cancer Treatment through Innovative Technology
Discover the potential of our disruptive technology and join us in the fight against cancer.
67 Cours Mirabeau
13100 Aix-en-Provence
FRANCE
info@oncoelectronics.com